Weill Cornell Medicine Events

CTL Enterprise Seminar – The Nuts and Bolts of University-based Startups

Learn from Wilson Sonsini Goodrich & Rosati (WSGR) about the nuts and bolts of University-based Startups.

Join us for an overview and active discussion with deeply experienced professionals from Silicon Valley, hear their perspective on:

  • Creating Business Plans
  • Licensing University Technologies
  • Raising Capital

 

Katharine “Kathy” Ku, Chief Licensing Advisor, Wilson Sonsini Goodrich & Rosati – Palo Alto office

Kathy served as the Executive Director of Stanford University’s Office of Technology Licensing (OTL) for 27 years. During that period, OTL licensed out hundreds of new technologies, bringing in $1.8 billion, most of which went back to support research and education at Stanford.  Because Stanford’s OTL licensed many start-ups, including Google, Tableau, iRhythm, she understands the challenges of building a successful company through a robust intellectual property portfolio.

Kathy served as President of the Association of University Technology Managers.   She also spearheaded the development and implementation of nine principles related to university technology licensing. The principles are set forth in document entitled “In the Public Interest: Nine Points to Consider in Licensing University Technology.” More than 120 institutions have adopted the principles since they were published in 2007.

 

Matthew J. Meyer, Chief Client Corporate Development Advisor in the life sciences, Wilson Sonsini Goodrich & Rosati

Based in San Francisco, Matthew leads the firm’s life science business advisory practice—a newly formed, innovative resource aimed at providing start-up and emerging life sciences companies with business insights, capabilities, and strategies to help them thrive and address some of their most challenging issues.

Matthew is an experienced executive and corporate attorney who has held diverse roles of increasing responsibility across a wide range of private and public biopharma, medtech, and precision medicine companies from start-ups to Fortune 50 in the U.S. and Europe, including Pfizer, Novartis, and CareDx. His leadership capabilities include delivery of strong commercial results, structuring and executing partnering transactions across the product life cycle, raising debt and equity capital in the private and public markets, and working with founders, management teams, and boards to address complex business issues to support rapid growth.

 

For more information, please download a summary of the WSGR business advisory practice here.

Thursday, November 7 at 5:00pm to 6:00pm

Belfer Research Building, Room BB 302-C&D
413 East 69th St., New York, NY 10021

Event Type

Lecture/Seminar

Mission

Education

Website

https://ctl.cornell.edu/event/ctl-ent...

Cost

Free

Hashtag

##startups, #commercialization

Photo Alt Text

Our Guest Speakers

Subscribe
Google Calendar iCal Outlook

Recent Activity